| | | Index Performance | | Index | Sensex | Nifty | | Open | 13,602.90 | 3,989.60 | | High | 13,762.92 | 4,039.25 | | Low | 13,602.90 | 3,981.75 | | Today's Cls | 13,672.19 | 4,011.60 | | Prev Cls | 13,607.04 | 3,984.95 | | Change | 65.15 | 26.65 | | % Change | 0.48 | 0.67 | | | | Market Indicators | | Top Movers (Group A) | | Company | Price
(Rs) | %
chg | | Gainers | | GTL | 164.10 | 17.55 | | Sterling Biotech | 166.70 | 16.13 | | BASF India | 219.95 | 9.48 | | HCL Tech | 323.70 | 7.22 | | Dabur India | 98.90 | 5.16 | | Losers | | iGate Global | 332.35 | -5.58 | | Siemens | 1,061.55 | -4.65 | | CESC | 384.30 | -3.91 | | BPCL | 320.45 | -3.86 | | Jaiprakash Associates | 570.95 | -3.35 | | | Market Statistics | | - | BSE | NSE | | Advances | 1,341 | 783 | | Declines | 1,232 | 662 | | Unchanged | 88 | 49 | | Volume(Nos) | 23.12cr | 33.42cr | | | | | | Market Commentary | | | Sensex ends on a bullish note | | The Sensex held firm throughout the trading session and closed with gains of 65 points. | | After yesterday’s fall the market saw an upmove during the day on sustained buying in heavyweight, banking and pharma stocks. | | | The Sensex opened with a negative gap of four points but soon gained momentum and moved into positive territory. The Sensex gyrated by over 100 points in early trades and surged to touch the day's high of 13763. However, the market eased towards the close on selling in auto, engineering and metal stocks. The Sensex ended the session with gains of 65 points at 13672 while the Nifty closed at 4012, up 27 points.
| | Movers & Shakers | - Valecha Engineering closed in the red despite bagging orders worth Rs100 crore for roads in various states and an order from Delhi Metro Rail Corporation.
- Petron Engineering notched up gains on bagging an order from a Chinese firm worth Rs37.76 crore.
- Reliance Capital gained after the company made an open offer for the acquisition of 20% stake of TV Today at Rs130.50 per share.
| | | | The breadth of the market was positive. Of the 2,661 stocks traded on the BSE, 1,341 stocks advanced, 1,232 stocks declined and 88 stocks ended unchanged. Among the sectoral indices the BSE HC Index gained 1.56%, the BSE PSU Index rose 1.40% and the BSE Bankex was up 1.07%.
Most of the Sensex stocks ended at higher levels. NTPC surged 3.12% at Rs162, SBI soared 2.65% at Rs1,035, Wipro gained 2.09% at Rs586, Bharti Airtel added 1.64% at Rs813, ONGC advanced 1.64% at Rs906, Cipla gained 1.39% at Rs233, Hindalco jumped 1.33% at Rs145 and ACC was up 1.25% at Rs817.
Pharma stocks were in demand and attracted strong buying support. Sterling Biotech spurted 16.13% at Rs167, Sun Pharma gained 3.40% at Rs1,151, Glenmark Pharma added 3.23% at Rs665 and Biocon advanced 2.24% at Rs524. Matrix, Wyeth Lab, Divis Lab and Wockhardt gained around 1% each.
Over 1.88 crore Dish TV shares changed hands on the BSE followed by IFCI (77.13 lakh shares), Himachal Futuristic (75.45 lakh shares), Tata Steel (47.55 lakh shares) and Hindustan Oil Exploration (47.09 lakh shares).
Value-wise ICRA clocked a turnover of Rs391 crore followed by Tata Steel (Rs241 crore), Dish TV (Rs201 crore), Reliance Industries (Rs80 crore) and Page Industries (Rs79 crore). | | | | | | | | European Indices at 16:20 IST on 18-04-2007 | | | | Index | Level | Change (pts) | Change (%) | | FTSE 100 | 6472.30 | -25.50 | -0.39 | | CAC 40 Index | 5848.98 | -9.16 | -0.16 | | DAX Index | 7304.83 | -44.00 | -0.60 | | | | | | | | | | | Asian Indices at close on 18-04-2007 | | | | Index | Level | Change (pts) | Change (%) | | Nikkei 225 | 17667.33 | 139.88 | 0.80 | | Hang Seng | 20777.09 | -11.52 | -0.06 | | Kospi Index | 1534.58 | 5.92 | 0.39 | | Straits Times Index | 3400.41 | -14.91 | -0.44 | | Jakarta Composite Index | 1959.68 | -5.76 | -0.29 | | | | | | | | | | | | “This document has been prepared by Sharekhan Ltd. This Document is subject to changes without prior notice and is intended only for the person or entity to which it is addressed to and may contain confidential and/or privileged material and is not for any type of circulation. Any review, retransmission, or any other use is prohibited. Kindly note that this document does not constitute an offer or solicitation for the purchase or sale of any financial instrument or as an official confirmation of any transaction.
Though disseminated to all the customers simultaneously, not all customers may receive this report at the same time. SHAREKHAN will not treat recipients as customers by virtue of their receiving this report.
The information contained herein is from publicly available data or other sources believed to be reliable. While we would endeavour to update the information herein on reasonable basis, SHAREKHAN, its subsidiaries and associated companies, their directors and employees (“SHAREKHAN and affiliates”) are under no obligation to update or keep the information current. Also, there may be regulatory, compliance, or other reasons that may prevent SHAREKHAN and affiliates from doing so. We do not represent that information contained herein is accurate or complete and it should not be relied upon as such. This document is prepared for assistance only and is not intended to be and must not alone betaken as the basis for an investment decision. The user assumes the entire risk of any use made of this information. Each recipient of this document should make such investigations as it deems necessary to arrive at an independent evaluation of an investment in the securities of companies referred to in this document (including the merits and risks involved), and should consult its own advisors to determine the merits and risks of such an investment. The investment discussed or views expressed may not be suitable for all investors. We do not undertake to advise you as to any change of our views. Affiliates of Sharekhan may have issued other reports that are inconsistent with and reach different conclusion from the information presented in this report.
This report is not directed or intended for distribution to, or use by, any person or entity who is a citizen or resident of or located in any locality, state, country or other jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which would subject SHAREKHAN and affiliates to any registration or licensing requirement within such jurisdiction. The securities described herein may or may not be eligible for sale in all jurisdictions or to certain category of investors. Persons in whose possession this document may come are required to inform themselves of and to observe such restriction.
SHAREKHAN & affiliates may have used the information set forth herein before publication and may have positions in, may from time to time purchase or sell or may be materially interested in any of the securities mentioned or related securities. SHAREKHAN may from time to time solicit from, or perform investment banking, or other services for, any company mentioned herein. Without limiting any of the foregoing, in no event shall SHAREKHAN, any of its affiliates or any third party involved in, or related to, computing or compiling the information have any liability for any damages of any kind. Any comments or statements made herein are those of the analyst and do not necessarily reflect those of SHAREKHAN.” | To unsubscribe write to myaccount@sharekhan.com
| |
No comments:
Post a Comment